Sandro Roberto Marana
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sandro Roberto Marana has a total of 173 co-authors. Here are the top co-authors by number of shared publications:
Clélia Ferreira
11 shared publicationsWalter R. Terra
Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, C.P. 26077, 05513-970, São Paulo, Brazil
8 shared publications- Vitor Medeiros Almeida
Department of Biochemistry, Institute of Chemistry, University of São Paulo, Av Prof Lineu Prestes 748, Building 12, São Paulo 05508-000, SP, Brazil
7 shared publications - Guilherme Menegon Arantes
Department of Biochemistry, Instituto de Química, Universidade de São Paulo, Av. Prof. Lineu Prestes 748, 05508-900 São Paulo, SP, Brazil
6 shared publications - Igor Polikarpov
São Carlos Institute of Physics, University of São Paulo, São Carlos, Brazil
5 shared publications - Maria Teresa Machini
University of São Paulo Avenida Prof. Lineu Prestes 748
4 shared publications
Latest Publications
- Open Access
Semantic networks as a tool for analyzing conceptual organization in active teaching methodologies in Microbiology
Active teaching methodologies have been widely used to promote meaningful learning and student autonomy. In this context, quantitative approaches can help assess how students organize and integrate knowledge throughout the learning process. Among these approaches, semantic co-occurrence networks stand out, as they are capable of identifying relationships between words and revealing the conceptual structure of textual productions. The objective of this study was to investigate whether semantic network analyses can characterize differences in students’ conceptual organization in Microbiology during their participation in the active teaching methodology “Adopt a Bacterium.” To this end, a case study was conducted in the Bacteriology course at the Institute of Biomedical Sciences of the University of São Paulo, analyzing the textual productions of two groups of students in the years 2024 and 2025 during their study of the bacterial genus Bacillus . The texts were evaluated using semantic co-occurrence networks, taking into account metrics of structure and conceptual integration. The results showed that both groups covered the microbiological content outlined in the course, though with different thematic focuses and approaches to integrating the concepts. Although both years featured modular structures (a statistical mode of 9 subgraphs), in 2025 the network exhibited greater discursive robustness (2 to 4 times more words with high Betweenness centrality) than in 2024. It is concluded that semantic network analysis allows for the characterization of differences in conceptual organization among students using active learning methodologies, serving as a complementary tool for assessing meaningful learning in Microbiology.
Open AccessSemantic networks as a tool for analyzing conceptual organization in active teaching methodologies in Microbiology
Active teaching methodologies have been widely used to promote meaningful learning and student autonomy. In this context, quantitative approaches can help assess how students organize and integrate knowledge throughout the learning process. Among these approaches, semantic co-occurrence networks stand out, as they are capable of identifying relationships between words and revealing the conceptual structure of textual productions. The objective of this study was to investigate whether semantic network analyses can characterize differences in students’ conceptual organization in Microbiology during their participation in the active teaching methodology “Adopt a Bacterium.” To this end, a case study was conducted in the Bacteriology course at the Institute of Biomedical Sciences of the University of São Paulo, analyzing the textual productions of two groups of students in the years 2024 and 2025 during their study of the bacterial genus Bacillus . The texts were evaluated using semantic co-occurrence networks, taking into account metrics of structure and conceptual integration. The results showed that both groups covered the microbiological content outlined in the course, though with different thematic focuses and approaches to integrating the concepts. Although both years featured modular structures (a statistical mode of 9 subgraphs), in 2025 the network exhibited greater discursive robustness (2 to 4 times more words with high Betweenness centrality) than in 2024. It is concluded that semantic network analysis allows for the characterization of differences in conceptual organization among students using active learning methodologies, serving as a complementary tool for assessing meaningful learning in Microbiology.
- Open Access
- 13 October 2025
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 68 (20) , 21665-21682
Development of a Potent and Functional In Vivo Peptide Competitive Inhibitor for the Toxin MazF
Cell growth regulation granted by toxin–antitoxin systems enables bacteria to fight phage infections, evade host immune defenses, and survive antibiotic treatment. In this work, a potent and specific peptide competitive inhibitor for the Escherichia coli toxin MazF was developed and named Small Antitoxin of MazF (SamF). Employing a set of N-acetylated and C-amidated synthetic peptides, biophysical methods, biochemistry, and molecular biology techniques, we demonstrated that SamF binds tightly and with high specificity to MazF in vitro and in vivo, blocking access to the substrate binding site. Coexpression of SamF with MazF in E. coli efficiently counteracted the metabolic downregulation imposed by the toxin and the formation of antibiotic persisters. Altogether, our data uncovered a new MazF druggable site and an excellent scaffold for the design of antimicrobials. SamF is also a promising tool to study MazF in vitro and its physiological function in bacteria.
- 13 October 2025
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 68 (20) , 21665-21682
Open AccessDevelopment of a Potent and Functional In Vivo Peptide Competitive Inhibitor for the Toxin MazF
Cell growth regulation granted by toxin–antitoxin systems enables bacteria to fight phage infections, evade host immune defenses, and survive antibiotic treatment. In this work, a potent and specific peptide competitive inhibitor for the Escherichia coli toxin MazF was developed and named Small Antitoxin of MazF (SamF). Employing a set of N-acetylated and C-amidated synthetic peptides, biophysical methods, biochemistry, and molecular biology techniques, we demonstrated that SamF binds tightly and with high specificity to MazF in vitro and in vivo, blocking access to the substrate binding site. Coexpression of SamF with MazF in E. coli efficiently counteracted the metabolic downregulation imposed by the toxin and the formation of antibiotic persisters. Altogether, our data uncovered a new MazF druggable site and an excellent scaffold for the design of antimicrobials. SamF is also a promising tool to study MazF in vitro and its physiological function in bacteria.
- Open Access
- 24 September 2025
- Published by Wiley in FEBS Open Bio
- Vol. 16 (2) , 365-381
A general model for analysis of linear and hyperbolic enzyme inhibition mechanisms
The mechanisms of reversible inhibitors with a single binding site on enzymes are usually divided into two basic groups: linear and hyperbolic (or partial). Each of these two groups is subdivided into three types: competitive, non‐competitive and mixed. These six mechanisms are often considered separate identities. Here, prompted by the characterization of the inhibition of the wild‐type and mutant β‐glucosidase Sfβgly by imidazole and 2‐amino‐2‐(hydroxymethyl)‐1,3‐propanediol (i.e. Tris), we developed a unifying enzyme kinetic model that integrates these six basic inhibition mechanisms into one. From this model, we deduced a general enzyme kinetic equation that, through modulation of simple parameters (i.e. the relative inhibitor affinity for two binding sites and the reactivity of the enzyme–substrate–inhibitor complex) is converted into the particular kinetic equation of each of those six inhibition mechanisms. In short, we conclude that the six fundamental inhibition mechanisms, linear and hyperbolic, are not separate behaviors but facets of the same general kinetic model presented here.
- 24 September 2025
- Published by Wiley in FEBS Open Bio
- Vol. 16 (2) , 365-381
Open AccessA general model for analysis of linear and hyperbolic enzyme inhibition mechanisms
The mechanisms of reversible inhibitors with a single binding site on enzymes are usually divided into two basic groups: linear and hyperbolic (or partial). Each of these two groups is subdivided into three types: competitive, non‐competitive and mixed. These six mechanisms are often considered separate identities. Here, prompted by the characterization of the inhibition of the wild‐type and mutant β‐glucosidase Sfβgly by imidazole and 2‐amino‐2‐(hydroxymethyl)‐1,3‐propanediol (i.e. Tris), we developed a unifying enzyme kinetic model that integrates these six basic inhibition mechanisms into one. From this model, we deduced a general enzyme kinetic equation that, through modulation of simple parameters (i.e. the relative inhibitor affinity for two binding sites and the reactivity of the enzyme–substrate–inhibitor complex) is converted into the particular kinetic equation of each of those six inhibition mechanisms. In short, we conclude that the six fundamental inhibition mechanisms, linear and hyperbolic, are not separate behaviors but facets of the same general kinetic model presented here.
- Open Access
- 7 August 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (32) , 35965-35974
Impact of Changes in Buffer Ionic Concentration and Mutations on a GH1 β-Glucosidase Homodimer
Oligomerization is a key feature of protein function, with approximately 30% of proteins exhibiting this trait. The homodimeric form of proteins, such as the GH1 β-glucosidase from (Sfβgly), plays a significant role in enzyme activity. In this study, we investigate the homodimerization of Sfβgly, which forms a cyclic C2 dimer with a well-defined interface. Using size exclusion chromatography and SEC-MALS, we characterized the homodimerization behavior of Sfβgly at equilibrium conditions in different ionic concentrations of phosphate buffer. The dissociation constants (K D) increase with decreasing ionic concentration, suggesting that the hydrophobic effect is central to homodimer formation. Site-directed mutagenesis of key residues at the dimer interface further elucidated the contributions of specific amino acid residues to dimer stability. Mutations affecting both, apolar and hydrogen bond-forming residues, significantly increased the K D. However, mutations of hydrogen bond-forming residues caused a smaller K D change than apolar residue mutations, suggesting that while the latter is the driving factor in the dimerization, the former could play a role in guiding the monomers relative orientation. These findings enhance our understanding of protein oligomerization in GH1 β-glucosidases and its implications for protein design and function.
- 7 August 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (32) , 35965-35974
Open AccessImpact of Changes in Buffer Ionic Concentration and Mutations on a GH1 β-Glucosidase Homodimer
Oligomerization is a key feature of protein function, with approximately 30% of proteins exhibiting this trait. The homodimeric form of proteins, such as the GH1 β-glucosidase from (Sfβgly), plays a significant role in enzyme activity. In this study, we investigate the homodimerization of Sfβgly, which forms a cyclic C2 dimer with a well-defined interface. Using size exclusion chromatography and SEC-MALS, we characterized the homodimerization behavior of Sfβgly at equilibrium conditions in different ionic concentrations of phosphate buffer. The dissociation constants (K D) increase with decreasing ionic concentration, suggesting that the hydrophobic effect is central to homodimer formation. Site-directed mutagenesis of key residues at the dimer interface further elucidated the contributions of specific amino acid residues to dimer stability. Mutations affecting both, apolar and hydrogen bond-forming residues, significantly increased the K D. However, mutations of hydrogen bond-forming residues caused a smaller K D change than apolar residue mutations, suggesting that while the latter is the driving factor in the dimerization, the former could play a role in guiding the monomers relative orientation. These findings enhance our understanding of protein oligomerization in GH1 β-glucosidases and its implications for protein design and function.
- Open Access
A general model for analysis of linear and hyperbolic enzyme inhibition mechanisms
The mechanisms of reversible inhibitors with a single binding site on enzymes are usually divided into basic groups: linear and hyperbolic, also called partial. Each of them subdivided into types: competitive, non-competitive and mixed. These six mechanisms are often considered separate identities. Here, prompted by the characterization of the inhibition of the wild-type and mutant β-glucosidase Sfβgly by Imidazole and Tris (2-amino-2-(hydroxymethyl)-1,3-propanediol) we developed a unifying enzyme kinetic model that integrates these six basic inhibition mechanism onto a single one. From this model we deduced a general enzyme kinetic equation that through modulation of simple parameters, i.e. the relative inhibitor affinity for two binding sites and the reactivity of the enzyme-substrate-inhibitor complex, is converted into the particular kinetic equation of each of those six inhibition mechanism. In short, we conclude that six fundamental inhibition mechanisms, linear and hyperbolic, are not isolate compartments, but actually facets of the same general model here presented.
Open AccessA general model for analysis of linear and hyperbolic enzyme inhibition mechanisms
The mechanisms of reversible inhibitors with a single binding site on enzymes are usually divided into basic groups: linear and hyperbolic, also called partial. Each of them subdivided into types: competitive, non-competitive and mixed. These six mechanisms are often considered separate identities. Here, prompted by the characterization of the inhibition of the wild-type and mutant β-glucosidase Sfβgly by Imidazole and Tris (2-amino-2-(hydroxymethyl)-1,3-propanediol) we developed a unifying enzyme kinetic model that integrates these six basic inhibition mechanism onto a single one. From this model we deduced a general enzyme kinetic equation that through modulation of simple parameters, i.e. the relative inhibitor affinity for two binding sites and the reactivity of the enzyme-substrate-inhibitor complex, is converted into the particular kinetic equation of each of those six inhibition mechanism. In short, we conclude that six fundamental inhibition mechanisms, linear and hyperbolic, are not isolate compartments, but actually facets of the same general model here presented.
- Open Access
- 25 March 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (3) , e0320120
Tris inhibits a GH1 β-glucosidase by a linear mixed inhibition mechanism
Here we demonstrate that Tris (2-amino-2-(hydroxymethyl)-1,3-propanediol), largely used as a buffering agent, is a linear mixed inhibitor (Ki = 12 ± 2 mM and α = 3 ± 1) of the GH1 β-glucosidase from the insect Spodoptera frugiperda (Sfβgly). Such an inhibition mechanism implies the formation of a non-productive ESI complex involving Sfβgly, substrate, and Tris. In addition, Tris binding reduces by 3 fold the enzyme affinity for the substrate. Hence, at concentrations higher than the Ki, Tris can completely abolish Sfβgly activity, whereas even at lower concentrations the presence of Tris causes underestimation of β-glucosidase kinetic parameters (Km and kcat). In agreement with the inhibition mechanism, computational docking showed that Tris could bind to a pocket placed at the lateral of the active site opening in the Sfβgly-substrate complex, hence leading to the formation of an ESI complex. In agreement with the crystallographic data available, computational docking also showed that Tris may find binding spots in the interior of the active site of the Sfβgly and several GH1 β-glucosidases. Moreover, the variety of their active site shapes results in a multiplicity of binding profiles, foreseeing different inhibition mechanisms. Thus, Tris inhibition may affect other GH1 β-glucosidases. This remark should be taken into account in their study, highlighting the importance of the appropriate buffer for accurate enzyme characterization.
- 25 March 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (3) , e0320120
Open AccessTris inhibits a GH1 β-glucosidase by a linear mixed inhibition mechanism
Here we demonstrate that Tris (2-amino-2-(hydroxymethyl)-1,3-propanediol), largely used as a buffering agent, is a linear mixed inhibitor (Ki = 12 ± 2 mM and α = 3 ± 1) of the GH1 β-glucosidase from the insect Spodoptera frugiperda (Sfβgly). Such an inhibition mechanism implies the formation of a non-productive ESI complex involving Sfβgly, substrate, and Tris. In addition, Tris binding reduces by 3 fold the enzyme affinity for the substrate. Hence, at concentrations higher than the Ki, Tris can completely abolish Sfβgly activity, whereas even at lower concentrations the presence of Tris causes underestimation of β-glucosidase kinetic parameters (Km and kcat). In agreement with the inhibition mechanism, computational docking showed that Tris could bind to a pocket placed at the lateral of the active site opening in the Sfβgly-substrate complex, hence leading to the formation of an ESI complex. In agreement with the crystallographic data available, computational docking also showed that Tris may find binding spots in the interior of the active site of the Sfβgly and several GH1 β-glucosidases. Moreover, the variety of their active site shapes results in a multiplicity of binding profiles, foreseeing different inhibition mechanisms. Thus, Tris inhibition may affect other GH1 β-glucosidases. This remark should be taken into account in their study, highlighting the importance of the appropriate buffer for accurate enzyme characterization.
- Open Access
Impact of changes in buffer ionic concentration and mutations on a GH1 β-Glucosidase homodimer
Oligomerization is a key feature of protein function, with approximately 30% of proteins exhibiting this trait. The homodimeric form of proteins, such as the GH1 β-Glucosidase from Spodoptera frugiperda (Sfβgly), plays a significant role in enzyme activity. In this study, we investigate the homodimerization of Sfβgly, which forms a cyclic C2 dimer with a well-defined interface. Using size exclusion chromatography and SEC-MALS, we characterized the homodimerization behavior of Sfβgly at equilibrium conditions in different ionic concentrations of phosphate buffer. The dissociation constants ( K D ) increase with decreasing ionic concentration, suggesting that the hydrophobic effect is central to homodimer formation. Site-directed mutagenesis of key residues at the dimer interface further elucidated the contributions of specific amino acid residues to dimer stability. Mutations affecting both, apolar and hydrogen bond-forming residues, significantly increased the K D . However, mutations of hydrogen bond-forming residues caused a smaller K D change than apolar residue mutations, suggesting that while the latter is the driving factor in the dimerization, the former may play a crucial role in guiding the monomers relative orientation. These findings enhance our understanding of protein oligomerization in GH1 β-Glucosidases and its implications for protein design and function.
Open AccessImpact of changes in buffer ionic concentration and mutations on a GH1 β-Glucosidase homodimer
Oligomerization is a key feature of protein function, with approximately 30% of proteins exhibiting this trait. The homodimeric form of proteins, such as the GH1 β-Glucosidase from Spodoptera frugiperda (Sfβgly), plays a significant role in enzyme activity. In this study, we investigate the homodimerization of Sfβgly, which forms a cyclic C2 dimer with a well-defined interface. Using size exclusion chromatography and SEC-MALS, we characterized the homodimerization behavior of Sfβgly at equilibrium conditions in different ionic concentrations of phosphate buffer. The dissociation constants ( K D ) increase with decreasing ionic concentration, suggesting that the hydrophobic effect is central to homodimer formation. Site-directed mutagenesis of key residues at the dimer interface further elucidated the contributions of specific amino acid residues to dimer stability. Mutations affecting both, apolar and hydrogen bond-forming residues, significantly increased the K D . However, mutations of hydrogen bond-forming residues caused a smaller K D change than apolar residue mutations, suggesting that while the latter is the driving factor in the dimerization, the former may play a crucial role in guiding the monomers relative orientation. These findings enhance our understanding of protein oligomerization in GH1 β-Glucosidases and its implications for protein design and function.
- Open Access
Tris inhibits a GH1 β-glucosidase by a linear mixed inhibition mechanism
Here we demonstrate that Tris (2-amino-2-(hydroxymethyl)-1,3-propanediol), largely used as buffering agent, is a linear mixed inhibitor ( K i = 12 ± 2 mM and α = 3 ± 1) of the GH1 β-glucosidase from the insect Spodoptera frugiperda (Sfβgly). Such inhibition mechanism implies in the formation of a non-productive ESI complex involving Sfβgly, substrate and Tris. In addition, Tris binding reduces by 3 fold the enzyme affinity for the substrate. Hence, at concentrations higher than the K i , Tris can completely abolish Sfβgly activity, whereas even at lower concentrations the presence of Tris causes underestimation of β-glucosidase kinetic parameters ( K m and k cat ). In agreement to the inhibition mechanism, computational docking showed that Tris could bind to a pocket placed at the lateral of the active site opening in the Sfβgly-substrate complex, hence leading to the formation of a ESI complex. Computational docking also showed that Tris may find binding spots in the interior of the active site of the Sfβgly and several GH1 β-glucosidases. Moreover, the variety of their active site shapes results in a multiplicity of binding profiles, foreseeing different inhibition mechanism. Thus, Tris inhibition is probably common among GH1 β-glucosidases. This remark should be taken into account in their study, highlighting the importance of the appropriate buffer for accurate enzyme characterization.
Open AccessTris inhibits a GH1 β-glucosidase by a linear mixed inhibition mechanism
Here we demonstrate that Tris (2-amino-2-(hydroxymethyl)-1,3-propanediol), largely used as buffering agent, is a linear mixed inhibitor ( K i = 12 ± 2 mM and α = 3 ± 1) of the GH1 β-glucosidase from the insect Spodoptera frugiperda (Sfβgly). Such inhibition mechanism implies in the formation of a non-productive ESI complex involving Sfβgly, substrate and Tris. In addition, Tris binding reduces by 3 fold the enzyme affinity for the substrate. Hence, at concentrations higher than the K i , Tris can completely abolish Sfβgly activity, whereas even at lower concentrations the presence of Tris causes underestimation of β-glucosidase kinetic parameters ( K m and k cat ). In agreement to the inhibition mechanism, computational docking showed that Tris could bind to a pocket placed at the lateral of the active site opening in the Sfβgly-substrate complex, hence leading to the formation of a ESI complex. Computational docking also showed that Tris may find binding spots in the interior of the active site of the Sfβgly and several GH1 β-glucosidases. Moreover, the variety of their active site shapes results in a multiplicity of binding profiles, foreseeing different inhibition mechanism. Thus, Tris inhibition is probably common among GH1 β-glucosidases. This remark should be taken into account in their study, highlighting the importance of the appropriate buffer for accurate enzyme characterization.
- Open Access
- 25 March 2023
- Published by Wiley in FEBS Open Bio
- Vol. 13 (5) , 912-925
Mechanism of imidazole inhibition of a GH1 β‐glucosidase
Imidazole is largely employed in recombinant protein purification, including GH1 β‐glucosidases, but its effect on the enzyme activity is rarely taken into consideration. Computational docking suggested that imidazole interacts with residues forming the active site of the GH1 β‐glucosidase from Spodoptera frugiperda (Sfβgly). We confirmed this interaction by showing that imidazole reduces the activity of Sfβgly, which does not result from enzyme covalent modification or promotion of transglycosylation reactions. Instead, this inhibition occurs through a partial competitive mechanism. Imidazole binds to the Sfβgly active site, reducing the substrate affinity by about threefold, whereas the rate constant of product formation remains unchanged. The binding of imidazole within the active site was further confirmed by enzyme kinetic experiments in which imidazole and cellobiose competed to inhibit the hydrolysis of p‐nitrophenyl β‐glucoside. Finally, imidazole interaction in the active site was also demonstrated by showing that it hinders access of carbodiimide to the Sfβgly catalytic residues, protecting them from chemical inactivation. In conclusion, imidazole binds in the Sfβgly active site, generating a partial competitive inhibition. Considering that GH1 β‐glucosidases share conserved active sites, this inhibition phenomenon is probably widespread among these enzymes, and this should be taken into account when considering the characterization of their recombinant forms.
- 25 March 2023
- Published by Wiley in FEBS Open Bio
- Vol. 13 (5) , 912-925
Open AccessMechanism of imidazole inhibition of a GH1 β‐glucosidase
Imidazole is largely employed in recombinant protein purification, including GH1 β‐glucosidases, but its effect on the enzyme activity is rarely taken into consideration. Computational docking suggested that imidazole interacts with residues forming the active site of the GH1 β‐glucosidase from Spodoptera frugiperda (Sfβgly). We confirmed this interaction by showing that imidazole reduces the activity of Sfβgly, which does not result from enzyme covalent modification or promotion of transglycosylation reactions. Instead, this inhibition occurs through a partial competitive mechanism. Imidazole binds to the Sfβgly active site, reducing the substrate affinity by about threefold, whereas the rate constant of product formation remains unchanged. The binding of imidazole within the active site was further confirmed by enzyme kinetic experiments in which imidazole and cellobiose competed to inhibit the hydrolysis of p‐nitrophenyl β‐glucoside. Finally, imidazole interaction in the active site was also demonstrated by showing that it hinders access of carbodiimide to the Sfβgly catalytic residues, protecting them from chemical inactivation. In conclusion, imidazole binds in the Sfβgly active site, generating a partial competitive inhibition. Considering that GH1 β‐glucosidases share conserved active sites, this inhibition phenomenon is probably widespread among these enzymes, and this should be taken into account when considering the characterization of their recombinant forms.
- Open Access
- 10 March 2023
- Published by MDPI AG in Pharmaceuticals
- Vol. 16 (3) , 428
Trypanosoma cruzi Sirtuin 2 as a Relevant Druggable Target: New Inhibitors Developed by Computer-Aided Drug Design
Trypanosoma cruzi, the etiological agent of Chagas disease, relies on finely coordinated epigenetic regulation during the transition between hosts. Herein we targeted the silent information regulator 2 (Sir2) enzyme, a NAD+-dependent class III histone deacetylase, to interfere with the parasites’ cell cycle. A combination of molecular modelling with on-target experimental validation was used to discover new inhibitors from commercially available compound libraries. We selected six inhibitors from the virtual screening, which were validated on the recombinant Sir2 enzyme. The most potent inhibitor (CDMS-01, IC50 = 40 μM) was chosen as a potential lead compound.
- 10 March 2023
- Published by MDPI AG in Pharmaceuticals
- Vol. 16 (3) , 428
Open AccessTrypanosoma cruzi Sirtuin 2 as a Relevant Druggable Target: New Inhibitors Developed by Computer-Aided Drug Design
Trypanosoma cruzi, the etiological agent of Chagas disease, relies on finely coordinated epigenetic regulation during the transition between hosts. Herein we targeted the silent information regulator 2 (Sir2) enzyme, a NAD+-dependent class III histone deacetylase, to interfere with the parasites’ cell cycle. A combination of molecular modelling with on-target experimental validation was used to discover new inhibitors from commercially available compound libraries. We selected six inhibitors from the virtual screening, which were validated on the recombinant Sir2 enzyme. The most potent inhibitor (CDMS-01, IC50 = 40 μM) was chosen as a potential lead compound.